» Articles » PMID: 35607991

Association of Human Leucocyte Antigen Class II, with Viral Load and Immune Response to Epstein-Barr Virus in Adult and Pediatric Systemic Lupus Erythematosus Patients

Overview
Journal Lupus
Publisher Sage Publications
Specialty Rheumatology
Date 2022 May 24
PMID 35607991
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease, which is known to be associated with HLA-DRB1 and Epstein-Barr virus (EBV) infection. In the Indian subcontinent where there is high seroendemicity of EBV, we postulated that the association of this virus in adult SLE (aSLE) and pediatric SLE (pSLE) patients would be different and differentially associate with the HLA-DRB1 susceptibility and protective genes.

Methods: A total of 109 aSLE, 52 pSLE, 215 adult healthy and 63 pediatric healthy controls were recruited. HLA-DRB1 genotyping by PCR-SSP, EBV load estimation by real-time PCR and antibody profiling (IgG & IgM) to EBV antigens by line blot assay were performed.

Results: DRB1*15 was found predominant in pSLE patients and DRB1*03 in aSLE patients. DRB1*15/X heterozygous was predominant in overall SLE patients, although disease severity, like hypocomplementemia, higher autoantibody levels and more organ involvement was observed in *15/*15 homozygous state. EBV strongly associated with pSLE patients showing higher percent of EA-D IgG ( < 0.0001) and p22 IgG ( = 0.035) along with higher viral load ( = 0.001) as compared to healthy controls. In addition, the higher EBV DNA load significantly associated with anti-EA-D IgG ( = 0.013) and DRB1*15/*15 ( = 0.007) in pSLE patients

Conclusions: This study therefore indicates that different HLA-DRB1 allotypes confer susceptibility to SLE in children and adults and disease may be triggered by increased EBV reactivation.

Citing Articles

Epstein-Barr Virus and Human Endogenous Retrovirus in Japanese Patients with Autoimmune Demyelinating Disorders.

Cossu D, Tomizawa Y, Sechi L, Hattori N Int J Mol Sci. 2023; 24(24).

PMID: 38138980 PMC: 10743056. DOI: 10.3390/ijms242417151.


Epstein-Barr Virus Reactivation as a New Predictor of Achieving Remission or Lupus Low Disease Activity State in Patients with Systemic Lupus Erythematosus with Cutaneous Involvement.

Miskovic R, Cirkovic A, Miljanovic D, Jeremic I, Grk M, Basaric M Int J Mol Sci. 2023; 24(7).

PMID: 37047126 PMC: 10093904. DOI: 10.3390/ijms24076156.


Epstein‒Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus.

Chen X, Li H, Wu C, Zhang Y Virol J. 2023; 20(1):29.

PMID: 36782252 PMC: 9926755. DOI: 10.1186/s12985-023-01987-3.